CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare and Medicaid issues such as drug pricing. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Advance the use of FDA-approved medicines to treat addiction in criminal justice and public health settings. Confronting the opioid and mental illness epidemic including funding issues. Implementation of Comprehensive Addiction and Recovery Act of 2016 (P.L.114-198). Implementation of 21st Century Cures Act (P.L.114-255). Implementation of SUPPORT for Patients and Communities Act (P.L.115-271). H.R.3055/S.2584, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 and H.R.3055, the FY2020 Consolidated measure. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020 and H.R.2740, the FY2020 Consolidated measure.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.